bp-c2
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 19, 2014 (NCT03627390)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04186585 | Phase 1 | Mar 2, 2020 | Meabco A/S, Meddoc AS, Norwegian University of Life Sciences |
| NCT03627390 | Phase 2 | Dec 19, 2014 | Meabco A/S, Meddoc AS, Menoufia University, Norwegian University of Life Sciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Meabco A/S | For profit | 2 | 1 | 2 | 2014 |
| Meddoc AS | Academic/Hospital | 2 | 1 | 2 | 2014 |
| Norwegian University of Life Sciences | Academic/Hospital | 2 | 0 | 2 | 2014 |
| Menoufia University | Academic/Hospital | 1 | 0 | 1 | 2014 |
4 organizations
Page 1 / 1